Home

HARMONY

 

ALL: Delphi Survey Project: Towards a Core Outcome Set for Acute Lymphoblastic Leukemia (ALL)
PRESS RELEASE: New HARMONY CML Research Project will study the role of genetic aberrations in the disease course of Chronic Myeloid Leukemia.
PRESS RELEASE: HARMONY presents new insights in Chronic Lymphocytic Leukemia at EHA2021
Connect with us at the EHA2021 Virtual Congress and learn about new HARMONY results
#Bigdataforbloodcancer Blog: Selecting the right treatment for the right patient: The HARMONY approach.
#Bigdataforbloodcancer Blog: The HARMONY Alliance - a balance between Big Data and Cybersecurity, with a real impact on patients with Hematological tumors
CLL: Delphi Survey Project: Towards a Core Outcome Set for Chronic Lymphocytic Leukemia
MM 2: Contextualizing clinical trials by developing robust historical control arm cohort
AML 4: Using big data to confirm the link between MRD and survival in AML
AML 3: Using big data to shed light on the clinical impact of genomic alterations in sAML/tAML
ALL 4: Harnessing the Power of Big Data to Predict Outcomes Post-Stem Cell Transplant in Adult R/R ALL
ALL 3: Exploring treatment patterns and outcomes in older adult B-ALL
MM: Delphi Survey Project: Towards a Core Outcome Set for Multiple Myeloma
MDS: Delphi Survey Project: Towards a Core Outcome Set for Myelodysplastic Syndromes
ALL 2: Prognostic Value of IKZF1 Gene Alternations in Adult BCP ALL
NHL: Delphi Survey Project: Towards a Core Outcome Set for Non-Hodgkin Lymphoma
ALL: Delphi Survey Project: Towards a Core Outcome Set for Acute Lymphoblastic Leukemia (ALL)
AML: Delphi Survey: Towards a Core Outcome Set for Acute Myeloid Leukemia
NHL: Using big data to optimize outcomes in T-cell Non-Hodgkin Lymphomas
MM 1: Optimizing prognostication and personalizing treatment in Multiple Myeloma
MDS: Prognostic factors to hypomethylating agents and intensive chemotherapy in higher risk Myelodysplastic Syndromes
CLL: Harnessing big data to predict prognosis in Chronic Lymphocytic Leukemia
AML 2: Optimizing Acute Promyelocytic Leukemia Management Using Big Data
AML 1: Use of Big Data to revise treatment strategies in Acute Myeloid Leukemia
1-24   25-48